Cyclic strain of poly (methyl methacrylate) surfaces triggered the pathogenicity of Candida albicans.


Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
15 10 2023
Historique:
received: 15 05 2023
revised: 21 07 2023
accepted: 17 08 2023
pmc-release: 15 10 2024
medline: 9 10 2023
pubmed: 26 8 2023
entrez: 25 8 2023
Statut: ppublish

Résumé

Candida albicans is an opportunistic yeast and the primary etiological factor in oral candidiasis and denture stomatitis. The pathogenesis of C. albicans could be triggered by several variables, including environmental, nutritional, and biomaterial surface cues. Specifically, biomaterial interactions are driven by different surface properties, including wettability, stiffness, and roughness. Dental biomaterials experience repetitive (cyclic) stresses from chewing and biomechanical movements. Pathogenic biofilms are formed over these biomaterial surfaces under cyclic strain. This study investigated the effect of the cyclic strain (deformation) of biomaterial surfaces on the virulence of Candida albicans. Candida biofilms were grown over Poly (methyl methacrylate) (PMMA) surfaces subjected to static (no strain) and cyclic strain with different levels (ε˜

Identifiants

pubmed: 37625677
pii: S1742-7061(23)00501-9
doi: 10.1016/j.actbio.2023.08.037
pmc: PMC10705016
mid: NIHMS1926948
pii:
doi:

Substances chimiques

Polymethyl Methacrylate 9011-14-7
Transcription Factors 0
Methacrylates 0
Biocompatible Materials 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-426

Subventions

Organisme : NIDCR NIH HHS
ID : R21 DE030564
Pays : United States

Informations de copyright

Copyright © 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

PLoS Pathog. 2012;8(4):e1002585
pubmed: 22496639
Front Immunol. 2017 Jun 07;8:629
pubmed: 28638380
mBio. 2014 Nov 11;5(6):e01911
pubmed: 25389175
Nat Rev Microbiol. 2011 Aug 16;9(10):737-48
pubmed: 21844880
Nanomaterials (Basel). 2020 Apr 25;10(5):
pubmed: 32344901
PLoS One. 2016 Nov 30;11(11):e0167470
pubmed: 27902776
Clin Oral Investig. 2007 Sep;11(3):231-6
pubmed: 17333305
J Indian Prosthodont Soc. 2010 Dec;10(4):219-25
pubmed: 22131667
Curr Opin Microbiol. 2006 Aug;9(4):340-5
pubmed: 16815078
Adv Colloid Interface Sci. 2021 Feb;288:102336
pubmed: 33421727
PLoS Pathog. 2006 Jul;2(7):e63
pubmed: 16839200
APMIS. 2023 Nov;131(11):636-653
pubmed: 36932821
Mol Microbiol. 2008 Jul;69(1):201-17
pubmed: 18466294
Annu Rev Microbiol. 2002;56:187-209
pubmed: 12142477
Materials (Basel). 2021 Nov 18;14(22):
pubmed: 34832390
Front Cell Infect Microbiol. 2020 Jan 28;9:471
pubmed: 32047726
Clin Infect Dis. 2009 Mar 1;48(5):503-35
pubmed: 19191635
J Fungi (Basel). 2018 Dec 18;4(4):
pubmed: 30567300
Virulence. 2020 Dec;11(1):337-348
pubmed: 32274962
PLoS Pathog. 2012;8(4):e1002663
pubmed: 22536157
J Fungi (Basel). 2019 Feb 28;5(1):
pubmed: 30823468
J Fungi (Basel). 2021 Jan 22;7(2):
pubmed: 33499276
Infect Dis Obstet Gynecol. 1999;7(5):222-6
pubmed: 10524666
Arch Oral Biol. 2000 Jun;45(6):461-74
pubmed: 10775675
Eukaryot Cell. 2013 Feb;12(2):224-32
pubmed: 23223035
Front Cell Infect Microbiol. 2022 Jan 05;11:765942
pubmed: 35071033
Ann N Y Acad Sci. 1995 Mar 27;752:387-93
pubmed: 7755282
Monogr Oral Sci. 2021;29:155-194
pubmed: 33427213
J Prosthet Dent. 2010 May;103(5):309-18
pubmed: 20416415
Microorganisms. 2021 Jul 01;9(7):
pubmed: 34361863
Pathogens. 2021 Jul 07;10(7):
pubmed: 34358008
Ann Biomed Eng. 2001 Nov;29(11):923-34
pubmed: 11791675
Front Med (Lausanne). 2018 Feb 13;5:28
pubmed: 29487851
Nat Rev Microbiol. 2011 Feb;9(2):109-18
pubmed: 21189476
Curr Protein Pept Sci. 2020;21(3):313-323
pubmed: 31544690
FEMS Yeast Res. 2006 Nov;6(7):1074-84
pubmed: 17042757
J Prosthet Dent. 2023 Apr 18;:
pubmed: 37080861
Clin Microbiol Rev. 2007 Jan;20(1):133-63
pubmed: 17223626
Microbiol Mol Biol Rev. 2008 Sep;72(3):495-544
pubmed: 18772287
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
Cell Microbiol. 2004 Oct;6(10):915-26
pubmed: 15339267
Appl Environ Microbiol. 1989 Sep;55(9):2119-22
pubmed: 2679378
Nat Rev Microbiol. 2018 Dec;16(12):745-759
pubmed: 30301974
Front Microbiol. 2020 Nov 11;11:544480
pubmed: 33262741
BMC Biol. 2020 Sep 11;18(1):122
pubmed: 32912212
Cold Spring Harb Perspect Med. 2014 Oct 01;4(10):
pubmed: 25274758
Trends Microbiol. 2001 Jul;9(7):327-35
pubmed: 11435107
Acta Biomater. 2010 Jun;6(6):2307-13
pubmed: 19925892
Nat Rev Dis Primers. 2018 May 11;4:18026
pubmed: 29749387
PLoS Pathog. 2009 Oct;5(10):e1000612
pubmed: 19816560
Microbiol Res. 2022 May;258:126996
pubmed: 35247799
PLoS Pathog. 2009 Oct;5(10):e1000601
pubmed: 19798425
Mycoses. 2010 May;53(3):221-6
pubmed: 19671080
J Biol Chem. 2006 Dec 29;281(52):40399-411
pubmed: 17074760
EMBO J. 2001 Sep 3;20(17):4742-52
pubmed: 11532938
Front Bioeng Biotechnol. 2021 Feb 12;9:643722
pubmed: 33644027
J Fungi (Basel). 2018 Jan 11;4(1):
pubmed: 29371503
J Biol Chem. 2018 Mar 23;293(12):4304-4323
pubmed: 29386353
Cell Microbiol. 2006 Jun;8(6):961-71
pubmed: 16681837
Virulence. 2013 Feb 15;4(2):119-28
pubmed: 23302789
Connect Tissue Res. 2000;41(1):29-36
pubmed: 10826706
ACS Biomater Sci Eng. 2021 Oct 11;7(10):4838-4846
pubmed: 34596379
Trends Microbiol. 2018 Mar;26(3):229-242
pubmed: 29097091
J Oral Pathol Med. 2022 Jan;51(1):98-105
pubmed: 34859509
PLoS One. 2011;6(12):e28963
pubmed: 22194961
J Oral Pathol Med. 2020 Oct;49(9):835-841
pubmed: 32170981
J Clin Microbiol. 2001 Jul;39(7):2513-7
pubmed: 11427562
Eukaryot Cell. 2004 Jun;3(3):776-84
pubmed: 15189998
Microb Biotechnol. 2021 Jul;14(4):1353-1366
pubmed: 33252828
Eukaryot Cell. 2011 Sep;10(9):1173-82
pubmed: 21764907
Genome Biol. 2010;11(10):R106
pubmed: 20979621
Annu Rev Microbiol. 2000;54:49-79
pubmed: 11018124
J Biomech. 2000 Jun;33(6):729-35
pubmed: 10807994
PLoS One. 2018 Jun 18;13(6):e0197925
pubmed: 29912894
J Dent Res. 2010 Jul;89(7):657-65
pubmed: 20448246
Cardiovasc Res. 2006 Dec 1;72(3):375-83
pubmed: 17010955
Front Microbiol. 2020 Sep 17;11:538602
pubmed: 33042051
ACS Appl Bio Mater. 2020 Dec 21;3(12):8581-8591
pubmed: 35019629
Microbiology (Reading). 2003 Jan;149(Pt 1):261-7
pubmed: 12576599
Front Cell Infect Microbiol. 2021 Jan 25;10:594973
pubmed: 33569354
PLoS Pathog. 2017 Feb 23;13(2):e1006149
pubmed: 28231317
Mycoses. 2005 Nov;48(6):365-77
pubmed: 16262871
Mol Cell. 2012 Oct 12;48(1):52-62
pubmed: 22902555
EMBO J. 2004 Apr 21;23(8):1845-56
pubmed: 15071502
Trends Microbiol. 2017 Jan;25(1):62-75
pubmed: 27717660
Virulence. 2022 Dec;13(1):89-121
pubmed: 34964702
Arch Microbiol. 2000 Nov;174(5):362-74
pubmed: 11131027
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11965-70
pubmed: 21730141
Microbiology (Reading). 2015 Jan;161(Pt 1):18-29
pubmed: 25332379
Curr Opin Microbiol. 2009 Aug;12(4):365-70
pubmed: 19632143
J Fungi (Basel). 2020 Jan 16;6(1):
pubmed: 31963180
Clin Microbiol Rev. 2004 Apr;17(2):255-67
pubmed: 15084500
Nat Methods. 2008 Jul;5(7):621-8
pubmed: 18516045
Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25(1):e13-e20
pubmed: 31880295
J Biomech. 1995 Dec;28(12):1543-52
pubmed: 8666593
iScience. 2022 Mar 01;25(4):103994
pubmed: 35313695
mBio. 2021 Oct 26;12(5):e0252821
pubmed: 34607458
PLoS Pathog. 2016 Oct 20;12(10):e1005867
pubmed: 27764260
Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4668-76
pubmed: 20375342
Microbes Infect. 2016 May;18(5):310-21
pubmed: 26806384
Dent Mater. 2010 Sep;26(9):e211-9
pubmed: 20542552
Front Microbiol. 2020 Apr 30;11:794
pubmed: 32425915
Front Cell Infect Microbiol. 2022 Mar 22;12:855229
pubmed: 35392604
Genes (Basel). 2018 Nov 07;9(11):
pubmed: 30405082
Front Microbiol. 2018 Apr 05;9:647
pubmed: 29675005
J Dent Res. 2015 Aug;94(8):1027-34
pubmed: 26001706
Trends Microbiol. 2001 Apr;9(4):176-80
pubmed: 11286882
Colloids Surf B Biointerfaces. 2021 Apr;200:111570
pubmed: 33460965
Infect Immun. 1985 Oct;50(1):97-101
pubmed: 3899942
Biostatistics. 2012 Jul;13(3):523-38
pubmed: 22003245
Biomater Sci. 2021 Apr 21;9(8):3112-3126
pubmed: 33704333
Trends Microbiol. 2014 Dec;22(12):707-14
pubmed: 25262420
PLoS One. 2016 Mar 02;11(3):e0150457
pubmed: 26934196
Nat Rev Microbiol. 2008 Sep;6(9):667-73
pubmed: 18679170
Front Microbiol. 2022 Nov 03;13:911623
pubmed: 36406433
Genetics. 2000 Sep;156(1):31-44
pubmed: 10978273
Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):1797-1819
pubmed: 32372128
Med Mycol. 2001 Aug;39(4):303-13
pubmed: 11556759
Arch Oral Biol. 2020 May;113:104690
pubmed: 32155466
J Biotechnol. 2013 Mar 10;164(1):137-42
pubmed: 23262131
Clin Oral Investig. 2009 Sep;13(3):293-9
pubmed: 18810508
Curr Protein Pept Sci. 2012 Dec;13(8):739-55
pubmed: 23305361
Nanomaterials (Basel). 2022 Feb 07;12(3):
pubmed: 35159912
J Mater Sci Mater Med. 2019 Jun 19;30(7):77
pubmed: 31218489
J Fungi (Basel). 2021 Jan 22;7(2):
pubmed: 33499213

Auteurs

Carolina Montoya (C)

Department of Oral Health Sciences, Kornberg School of Dentistry, Temple University, Philadelphia, PA, United States.

Julia Kurylec (J)

Department of Oral Health Sciences, Kornberg School of Dentistry, Temple University, Philadelphia, PA, United States.

Alex Ossa (A)

Production Engineering Department, School of Engineering, Universidad EAFIT, Medellín, Colombia.

Santiago Orrego (S)

Department of Oral Health Sciences, Kornberg School of Dentistry, Temple University, Philadelphia, PA, United States; Bioengineering Department, College of Engineering, Temple University, Philadelphia, PA, United States. Electronic address: sorrego@temple.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH